The MFDS is planning to disclose the 'generic competitiveness strengthening plan' discussed through the public-private association in the near future.

Some negotiated content has been reported. However, the main part of the generic policy seems to be known only when the final proposal is issued. The industry believes that the impact on the industry will also be enormous. These are tasks such as the introduction of INN (international nonproprietary names) in generic products.

Currently, it is not possible to know whether the 'generic competitiveness strengthening plan' is a deregulation or a strengthening of regulations.

The 'unification of authorized generics', which was fi